ATEA PHARMACEUTICALS INC's ticker is AVIR and the CUSIP is 04683R106. A total of 118 filers reported holding ATEA PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.35 and the average weighting 0.5%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $48 | -22.6% | 15,946 | -4.5% | 0.00% | 0.0% |
| Q2 2023 | $62 | +10.7% | 16,696 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $56 | -30.0% | 16,696 | 0.0% | 0.00% | -50.0% |
| Q4 2022 | $80 | -99.9% | 16,696 | -37.5% | 0.00% | -33.3% |
| Q3 2022 | $152,000 | -20.0% | 26,696 | 0.0% | 0.00% | -25.0% |
| Q2 2022 | $190,000 | -4.0% | 26,696 | -2.6% | 0.00% | 0.0% |
| Q1 2022 | $198,000 | -19.2% | 27,396 | 0.0% | 0.00% | -20.0% |
| Q4 2021 | $245,000 | +4.3% | 27,396 | +309.1% | 0.01% | 0.0% |
| Q3 2021 | $235,000 | – | 6,696 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ABG Innovation Capital Partners III GP Ltd | 1,265,631 | $27,186,000 | 91.01% |
| Yu Fan | 143,867 | $3,090,000 | 34.92% |
| AJU IB Investment Co., Ltd. | 1,745,331 | $37,490,000 | 21.62% |
| Bain Capital Life Sciences Investors, LLC | 5,615,659 | $120,624,000 | 7.90% |
| Cormorant Asset Management, LP | 6,411,355 | $137,716,000 | 4.68% |
| Ally Bridge Group (NY) LLC | 373,288 | $8,018,000 | 1.99% |
| RA Capital Management | 5,368,451 | $115,314,000 | 1.85% |
| Omega Fund Management, LLC | 746,868 | $16,043,000 | 1.82% |
| CM Management, LLC | 90,000 | $1,933,000 | 1.40% |
| SECTORAL ASSET MANAGEMENT INC | 538,884 | $11,575,000 | 0.94% |